🇺🇸 FDA
Company

Prime

Prime Medicine

PRME biotech USA

Quick answer

Prime is a biotech company (PRME) headquartered in CAMBRIDGE, MA, USA with 17 tracked pipeline programs.

Pipeline (17)

project

PG-011 nasal spray 0.6%(twice daily)

Seasonal Allergic Rhinitis

Phase 3 · small_molecule · active

1 trials project

PG-011Gel

Atopic Dermatitis

Phase 3 · small_molecule · active

1 trials project

Recommended treatment schedule

COVID-19

Phase 3 · small_molecule · terminated

1 trials project

Bemarituzumab

Gastric Cancer

Phase 2 · mab · completed

1 trials project

FP-1039

Endometrial Cancers With FGFR2 Mutations

Phase 2 · small_molecule · terminated

1 trials project

FPA008

Pigmented Villonodular Synovitis

Phase 2 · mab · completed

1 trials project

PM359

Chronic Granulomatous Disease

Phase 2 · mab · active

1 trials project

Pumecitinib Nasal Spray 0.3%

Seasonal Allergic Rhinitis

Phase 2 · small_molecule · active

1 trials project

Bemarituzumab

Gastrointestinal Cancer

Phase 1 · mab · completed

1 trials project

Cabiralizumab

Advanced Solid Tumors

Phase 1 · mab · completed

1 trials project

FP-1039

Advanced Cancer

Phase 1 · small_molecule · completed

1 trials project

FPA008

Healthy

Phase 1 · small_molecule · terminated

1 trials project

FPA144

Advanced Solid Tumors

Phase 1 · small_molecule · completed

1 trials project

FPA150

Breast Cancer

Phase 1 · mab · terminated

1 trials project

FPT155

Advanced Solid Tumors

Phase 1 · mab · terminated

1 trials project

PG-033

Lichen Simplex Chronicus

Phase 1 · small_molecule · active

1 trials project

Artificial intelligence in diagnosis

Artificial Intelligence (AI) in Diagnosis

Unknown · other · active

1 trials

Patents (8)

patent

US 12404275

Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12383582

Methods of treating chronic wounds with amniotic fluid having elevated levels of

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12377115

Combination immunotherapies for treatment of cancer

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12365719

CD80 extracellular domain polypeptides and their use in cancer treatment

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12319738

Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12304898

Quinolyl-containing compound and pharmaceutical composition, and use thereof

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12234302

Chitosan derivatives and methods for preparing the same

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12233119

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vac

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)